We are live on
!
Find out more
RG
Rathbones Group Portfolio holdings
AUM
$27.1B
1-Year Est. Return
20.2%
This Fund
S&P 500
This Quarter
Est. Return
+12.06%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.19%
AUM
$23.2B
AUM Growth
+$2.49B
(+12%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
2.01%
Top 10 Holdings %
Top 10 Hldgs %
36.73%
Holding
646
New
43
Increased
209
Reduced
225
Closed
19
Avg Time Held
18.5
quarters
Top 10 Avg Time Held
21.1
quarters
Top 20 Avg Time Held
20.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$108M |
| 2 |
Meta Platforms (Facebook)
META
|
+$64.4M |
| 3 |
Parker-Hannifin
PH
|
+$52M |
| 4 |
Marsh
MRSH
|
+$49.7M |
| 5 |
Motorola Solutions
MSI
|
+$48.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$65.2M |
| 2 |
Estee Lauder
EL
|
+$49.3M |
| 3 |
Walt Disney
DIS
|
+$44.4M |
| 4 |
Edwards Lifesciences
EW
|
+$37.2M |
| 5 |
DexCom
DXCM
|
+$31.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.32% |
| 2 | Financials | 20.51% |
| 3 | Consumer Discretionary | 11.26% |
| 4 | Healthcare | 9.5% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UROY
601
Uranium Royalty Corp
UROY
$1.52B
| $62.5K | ﹤0.01% |
25,000
| – | – |
2024 Q2
4 quarters
|
|
602
Silvercorp Metals
SVM
$2.28B
| $51.7K | ﹤0.01% |
12,225
| – | – |
2021 Q1
17 quarters
|
|
603
Recursion Pharmaceuticals
RXRX
$2.15B
| $50.8K | ﹤0.01% |
10,045
-100
| -1% | -$491 |
2024 Q4
2 quarters
|
|
604
Rocket Pharmaceuticals
RCKT
$272M
| $49K | ﹤0.01% |
20,000
-10,000
| -33% | -$50.7K |
2023 Q3
7 quarters
|
|
605
Vizsla Silver
VZLA
$1.24B
| $48.3K | ﹤0.01% |
16,375
| – | – |
2024 Q3
3 quarters
|
|
606
Plug Power
PLUG
$2.26B
| $43.6K | ﹤0.01% |
29,276
+390
| +1% | +$389 |
2023 Q3
7 quarters
|
|
607
Beyond Meat
BYND
$126M
| $40K | ﹤0.01% |
+382
| New | +$33.2K |
2025 Q2
0 quarters
|
|
608
GrafTech
EAF
$216M
| $39.2K | ﹤0.01% |
4,026
| – | – |
2025 Q1
1 quarter
|
|
609
Hain Celestial
HAIN
$56.3M
| $39K | ﹤0.01% |
+25,640
| New | +$59.9K |
2025 Q2
0 quarters
|
|
|
OGG
610
Osisko Gold Group
OGG
$869M
| $38.5K | ﹤0.01% |
18,000
| – | – |
2024 Q2
4 quarters
|
|
611
PepGen
PEPG
$172M
| $35.5K | ﹤0.01% |
32,003
| – | – |
2023 Q3
7 quarters
|
|
|
DVS
612
DELISTED
Dolly Varden Silver Corp
DVS
| $34.6K | ﹤0.01% |
+10,259
| New | +$30.7K |
2025 Q2
0 quarters
|
|
613
Americas Gold and Silver
USAS
$1.42B
| $33.9K | ﹤0.01% |
16,784
-38,200
| -69% | -$61.7K |
2023 Q3
7 quarters
|
|
614
Western Copper and Gold
WRN
$464M
| $33.5K | ﹤0.01% |
27,450
| – | – |
2024 Q2
4 quarters
|
|
615
Transocean
RIG
$6.25B
| $32.7K | ﹤0.01% |
12,632
| – | – |
2022 Q2
12 quarters
|
|
616
Lineage Cell Therapeutics
LCTX
$241M
| $31.8K | ﹤0.01% |
35,000
| – | – |
2023 Q3
7 quarters
|
|
617
enCore Energy
EU
$179M
| $28.5K | ﹤0.01% |
10,000
| – | – |
2024 Q2
4 quarters
|
|
618
Polestar Automotive Holding UK
PSNY
$752M
| $27.1K | ﹤0.01% |
843
| – | – |
2024 Q3
3 quarters
|
|
|
EMX
619
DELISTED
EMX Royalty
EMX
| $25.1K | ﹤0.01% |
10,000
| – | – |
2024 Q3
3 quarters
|
|
620
Iovance Biotherapeutics
IOVA
$6.6B
| $22.6K | ﹤0.01% |
13,154
-60,000
| -82% | -$149K |
2023 Q3
7 quarters
|
|
621
Ur-Energy
URG
$367M
| $21K | ﹤0.01% |
20,000
| – | – |
2023 Q1
9 quarters
|
|
622
New Found Gold
NFGC
$592M
| $16.2K | ﹤0.01% |
11,340
-13,333
| -54% | -$17.2K |
2024 Q2
4 quarters
|
|
623
MindWalk Holdings
HYFT
$66M
| $14.8K | ﹤0.01% |
14,000
| – | – |
2023 Q3
7 quarters
|
|
|
ILLR
624
DELISTED
TRILLER GROUP INC
ILLR
| $12.6K | ﹤0.01% |
1,350
| – | – |
2025 Q1
1 quarter
|
|
625
T1 Energy
TE
$945M
| $12.3K | ﹤0.01% |
10,000
| – | – |
2024 Q1
5 quarters
|
|
Similar funds
NIM
LP
RCMU
SC
SO
Rathbones Group's Q2 2025 Portfolio in Review
As of Q2 2025, Rathbones Group held 646 positions worth $23.2B, up 12% from $20.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Rathbones Group's Q2 2025 filing shows 43 new, 209 increased, 225 reduced and 19 closed positions. Its largest new stake was Defi Technologies: 2,799,330 shares worth $8.79M. The largest sale was UnitedHealth, an estimated $65.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.
- Rathbones Group's largest Q2 2025 buy was Defi Technologies: 2,799,330 shares worth $8.79M.
- Rathbones Group added most to CRH in Q2 2025, an estimated $108M increase.
- Rathbones Group's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $65.2M.
- Rathbones Group fully exited Enphase Energy in Q2 2025, selling an estimated $1.7M.
- Rathbones Group's ten largest holdings make up 37% of its $23.2B portfolio in Q2 2025.
- Rathbones Group opened 43 new positions and closed 19 in Q2 2025.
- Rathbones Group's portfolio value rose 12% quarter-over-quarter to $23.2B.
Based on Rathbones Group's 13F filing for Q2 2025, filed 7 Aug 2025.